GASTROGRAFIN

This brand name is authorized in Canada, Cyprus, Spain, Finland, Hong Kong, Croatia, Ireland, Japan, Malta, New Zealand, Poland, Singapore, United Kingdom, United States

Active ingredients

The drug GASTROGRAFIN contains a combination of these active pharmaceutical ingredients (APIs):

1 Sodium amidotrizoate
UNII V5403H8VG7 - DIATRIZOATE SODIUM
Read about Diatrizoic acid
2 Meglumine amidotrizoate
UNII 3X9MR4N98U - DIATRIZOATE MEGLUMINE
Read about Meglumine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
GASTROGRAFIN Gastroenteral solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
P01CB01 Meglumine antimonate P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01C Agents against leishmaniasis and trypanosomiasis → P01CB Antimony compounds
Discover more medicines within P01CB01
V08AA01 Diatrizoic acid V Various → V08 Contrast media → V08A X-ray contrast media, iodinated → V08AA Watersoluble, nephrotropic, high osmolar X-ray contrast media
Discover more medicines within V08AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 02228564
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 36270
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 027102
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 97577
Country: HK Department of Health Drug Office Identifier(s): 46076
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-901124749
Country: JP 医薬品医療機器総合機構 Identifier(s): 7211001X1030
Country: MT Medicines Authority Identifier(s): AA565/52601, MA1354/00201
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 2521
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100025994, 100293631
Country: SG Health Sciences Authority Identifier(s): 05846P
Country: US FDA, National Drug Code Identifier(s): 0270-0445

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.